References
- Oscier D, Owen R, Johnson S. Splenic marginal zone lymphoma. Blood Rev 2005; 19: 39–51
- Baró C, Salido M, Domingo A, Granada I, Colomo L, Serrano S, Sole F. Translocation t(9;14)(p13;q32) in cases of splenic marginal zone lymphoma. Haematologica 2005; 91: 1289–1291
- Offit K, Parsa N Z, Filippa D, Jhanwar S C, Chaganti R SK. t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. Blood 1992; 80: 2594–2599
- Jaffe E S, Harris N L, Stein H, Vardiman J W. Pathology and genetics of tumours of haemopoietic and lymphoid tissues. World Health Organisation Classification of Tumours. IARC, Lyon 2001
- Schop R F, Kuehl W M, Van Wier S A, Ahmann G J, Price-Troska T, Bailey R J, et al. Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood 2002; 100: 2996–3001
- Cook J R, Aguilera N I, Reshmi-Skarja S, Huang X, Yu Z, Gollin S M, et al. Lack of PAX-5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14). Hum Pathol 2004; 35: 447–454
- George T I, Wrede J E, Bangs C D, Cherry A M, Warnke R A, Arber D A. Low grade B-cell lymphomas with plasmacytic differentiation lack PAX-5 gene rearrangements. J Mol Diagn 2005; 7: 346–351
- Ackroyd S, O'Connor S JM, Owen R G. Rarity of IgH translocations in Waldeström macroglobulinemia. Cancer Genet Cytogenet 2005; 163: 77–80
- Avet-Loiseau H, Garad R, Lode L, Robillard N, Bataille R. 14q32 translocations discriminate IgM multiple myeloma from Waldestrom's macroglobulinemia. Semin Oncol 2003; 30: 153–155
- Chang H, Samiee S, Li D, Patterson B, Chen C I, Stewart A K. Analysis of IgH translocations, chromosome 13q14 and 17p13.1(p53) deletions by fluorescence in situ hybridization in Waldenstrom's macroglobulinemia: a single center study of 22 cases. Leukemia 2004; 18: 1160–1162
- Poppe B, De Paepe P, Michaux L, Dastugue N, Bastard C, Herens C, et al. PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements. Genes Chromosomes Cancer 2005; 44: 218–223
- Fasan O, Willmott C, Czepulkowski B, Baker A, Rees D, Salisbury J, et al. Epstein-Barr virus-related post-transplant lymphoproliferative disorder with t(9;14)(p11-12;q32). Cancer Genet Cytogenet 2003; 142: 134–136
- Andrieux J, Fert-Ferrer S, Copin M C, Huyghe P, Pocachard P, Lespinasse J, et al. Three new cases of non-Hodgkin lymphoma with t(9;14)(p13;q32). Cancer Genet Cytogenet 2003; 145: 65–69
- Daibata M, Taguchi T, Nemoto Y, Iwasaki S, Ohtsuki Y, Taguchi H. In vitro Epstein-Barr virus-immortalised lymphoma cell line carrying t(9;14)(p13;q32) chromosome abnormality, derived from splenic lymphoma with villous lymphocytes. Int J Cancer 2006; 118: 513–517
- Morrison A M, Jäger U, Chott A, Schebesta M, Haas O A, Busslinger M. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma. Blood 1998; 10: 3865–3878